Clinical Trial Update: A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 trial update for KJ015 in HER2-expressing solid tumors shows the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Cholangiocarcinoma
• Colorectal Cancer
• Gastric Cancer
• Gastroesophageal Junction Cancer
• Head and Neck Squamous Cell Carcinoma
• Non-small Cell Lung Cancer

Drugs mentioned

• KJ015

Snippet

Sponsor: Shanghai Bao Pharmaceuticals Co., Ltd. | Conditions: Gastric/Gastroesophageal Junction Cancer, Breast Cancer | Phase 1 | Status: NOT_YET_RECRUITING